Galmed Pharmaceuticals Ltd. buy StockNews.com
Start price
11.03.23
/
50%
€0.42
Target price
11.03.24
-
Performance (%)
-21.70%
End price
12.03.24
€0.33
Summary
This prediction ended on 12.03.24 with a price of €0.33. The price of Galmed Pharmaceuticals Ltd. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -21.70%. StockNews_com has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Galmed Pharmaceuticals Ltd. | -0.763% | -0.763% | -63.636% |
iShares Core DAX® | 3.054% | 0.066% | 16.889% |
iShares Nasdaq 100 | 4.389% | -2.130% | 31.443% |
iShares Nikkei 225® | 5.386% | -0.624% | 16.546% |
iShares S&P 500 | 2.955% | -0.948% | 26.821% |
Comments by StockNews_com for this prediction
In the thread Galmed Pharmaceuticals Ltd. diskutieren
Globus Medical, Inc. (NYSE: GMED) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for GMED provided by MarketBeat
In the thread Trading Galmed Pharmaceuticals Ltd.
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten